1 RYAN SPECIALTY REPORTS THIRD QUARTER 2026 RESULTS - Total Revenue grew 4.7%
1 RYAN SPECIALTY REPORTS THIRD QUARTER 2026 RESULTS - Total Revenue grew 4.7% year-over-year to $790.0 million - - Organic Revenue Growth Rate* of 4.0% year- over-year - - Net Income of $88.0 million , or $0.29 per diluted share - - Adjusted EBITDAC* grew 3.8% year-over-year to $244.4 million - - Adjusted Net Income* increased 4.1% year-over-year to $137.1 million - - Adjusted Diluted Earnings Per Share* grew 8.5% to $0.51 per diluted share - - Returned $173.7 million to shareholders, including $150.0 million of share repurchases and $23.7 million of dividends and distributions - October 29, 2026 | CHICAGO, IL — Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”), a leading international specialty insurance firm, today announced results for the third quarter ended September 30, 2026 . Third Quarter 2026 Highlights • Revenue grew 4.7% year-over-year to $790.0 million , compared to $754.6 million in the prior-year period • Organic Revenue Growth Rate* was 4.0% for the quarter, compared to 15.0% in the prior-year period • Net Income increased 40.6% year- over-year to $88.0 million , compared to $62.6 million in the prior-year period. Diluted Earnings Per Share was $0.29 • Adjusted EBITDAC* increased 3.8% to $244.4 million , compared to $235.5 million in the prior-year period • Adjusted EBITDAC Margin* of 30.9% , compared to 31.2% in the prior-year period • Adjusted Net Income* increased 4.1% to $137.1 million , compared to $131.7 million in the prior-year period • Adjusted Diluted Earnings Per Share* increased 8.5% to $0.51 , compared to $0.47 in the prior-year period • Returned $173.7 million to shareholders through $150.0 million of Class A common stock repurchases, representing 3.5 million shares, and $23.7 million in dividends and distributions “We are proud of our third quarter performance, in light of an increasingly challenging market and against our toughest year over year comparison,” said Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty. “We grew total revenue 4.7%, driven by organic growth of 4.0%. We grew Adjusted EBITDAC by 3.8% and Adjusted Diluted EPS by 8.5%. We continued investing back into our business, with our second largest hiring class in late 2025, and displayed disciplined expense management, leading to an Adjusted EBITDAC margin that is down only 30 basis points year to date. We also returned capital to shareholders of over $500 million through dividends, distributions, and share repurchases. These results reflect the strength of our brokers and underwriters, and of the durable, scalable platform we have strategically built. We are confident our team will continue to perform throughout this cycle and emerge even stronger.” “Our team delivered in the face of one of the most challenging markets we have ever seen, retaining high levels of existing business, winning significant new business, and building our pipelines,” added Timothy W. Turner, Chief Executive Officer of Ryan Specialty. “We continue to deliver for our clients through our differentiated talent, deep specialty expertise, and independence. We are investing in talent, technology, AI, and data that will widen our moat. We remain focused on controlling what we can control. We are well-positioned to keep winning and to create long- term value for our shareholders.”
* For a definition and a reconciliation of Organic revenue growth rate, Adjusted compensation and benefits expense, Adjusted compensation and benefits expense ratio, Adjusted general and administrative expense, Adjusted general and administrative expense ratio, Adjusted EBITDAC, Adjusted EBITDAC margin, Adjusted net income, Adjusted net income margin, and Adjusted diluted earnings per share to the most directly comparable GAAP measure, see “ Non-GAAP Financial Measures and Key Performance Indicators ” below. (1) Compensation and benefits expense ratio is defined as Compensation and benefits divided by Total revenue. (2) General and administrative expense ratio is defined as General and administrative expense divided by Total revenue. (3) Net income margin is defined as Net income divided by Total revenue. (4) See “ Note 10 , Earnings Per Share ” of the unaudited quarterly consolidated financial statements.
3 Third Quarter 2026 Review* Total revenue for the third quarter of 2026 was $790.0 million , an increase of 4.7% compared to $754.6 million in the prior- year period. This increase was primarily due to continued organic revenue growth of 4.0% , driven by new client wins, strong renewal retention, and expanded relationships with existing clients, coupled with continued flow into the specialty and E&S markets, and modest amounts of revenue from acquisitions completed within the trailing twelve months ended September 30, 2026 . We experienced growth across the majority of our casualty lines, offset by a moderate decline in our property portfolio. Total operating expenses for the third quarter of 2026 were $649.1 million , a 0.8% increase compared to $643.8 million in the prior-year period. This increase was primarily due to higher Compensation and benefits expenses resulting from growth in revenue and an increase in Restructuring and related expense due to the Empower Program, partially offset by a decrease in Acquisition-related expenses. General and administrative expense decreased compared to the prior-year period due to a decrease in Acquisition-related expenses, partially offset by an increase in Restructuring and related expense due to the Empower Program. Change in contingent consideration also decreased compared to the prior-year period. Net income for the third quarter of 2026 increased 40.6% to $88.0 million , compared to $62.6 million in the prior- year period, primarily driven by solid revenue growth and relatively flat Total operating expenses, partially offset by a higher Income tax expense. Adjusted EBITDAC grew 3.8% to $244.4 million from $235.5 million in the prior-year period. Adjusted EBITDAC margin for the quarter was 30.9% , compared to 31.2% in the prior-year period. The increase in Adjusted EBITDAC was driven primarily by solid revenue growth, partially offset by higher Adjusted compensation and benefits expense. Adjusted net income for the third quarter of 2026 increased 4.1% to $137.1 million , compared to $131.7 million in the prior-year period. Adjusted net income margin was 17.4% , compared to 17.5% in the prior-year period. Adjusted diluted earnings per share for the third quarter of 2026 increased 8.5% to $0.51 , compared to $0.47 in the prior-year period. * For the definition of each of the non-GAAP measures referred to above, as well as a reconciliation of such non-GAAP measures to their most directly comparable GAAP measures, see “Non-GAAP Financial Measures and Key Performance Indicators ” below.
Third Quarter 2026 Net Commissions and Fees by Specialty and Revenue by Type Growth in Net commissions and fees in all specialties was primarily driven by solid organic growth.
5 Liquidity and Financial Condition As of September 30, 2026 , the Company had Cash and cash equivalents of $168.8 million and outstanding debt principal of $3.7 billion . Capital Return In the third quarter, the Company returned approximately $173.7 million to shareholders through $150.0 million of Class A common stock repurchases, representing 3.5 million shares, and $23.7 million in dividends and distributions. As of September 30, 2026 , the Company had $150.0 million of remaining authorization under its share repurchase program. Additionally, on October 29, 2026 , the Company’s board of directors declared a quarterly dividend of $0.13 per share on the outstanding Class A common stock. The quarterly dividend will be payable on November 24, 2026 , to stockholders of record as of the close of business on November 10, 2026 . A portion of the dividend, $0.06 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company’s Class A common stock and the holders of the LLC Common Units (as defined below). Full Year 2026 Guidance* The Company is maintaining its full year 2026 guidance for Organic Revenue Growth Rate and updating its Adjusted EBITDAC Margin as follows: • We are guiding to an Organic Revenue Growth Rate in the mid-single digits for 2026 • We are guiding to an Adjusted EBITDAC Margin that is down modestly for 2026, as compared to the prior year * For a definition of Organic revenue growth rate and Adjusted EBITDAC margin, see “ Non-GAAP Financial Measures and Key Performance Indicators ” below. Conference Call Information Ryan Specialty will hold a conference call to discuss the financial results at 4:45pm Eastern Time on October 29, 2026 . Interested parties may access the conference call through the live webcast, which can be accessed at https:// ryan-specialty-q3-2026-earnings- call.open-exchange.net/registration or by visiting the Company’s Investor Relations website. Please join the live webcast at least 10 minutes prior to the scheduled start time. A webcast replay of the call will be available on the Company’s website at ryanspecialty.com in its Investors section for one year following the call. About Ryan Specialty Founded in 2010, Ryan Specialty (NYSE: RYAN) is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. Ryan Specialty provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. Our mission is to provide industry-leading innovative specialty insurance solutions for insurance brokers, agents, and carriers. Learn more at ryanspecialty.com. Forward-Looking Statements All statements in this release and in the corresponding earnings call that are not historical are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties. For example, all statements the Company makes relating to its estimated and projected costs, expenditures, cash flows, growth rates and financial results, its plans, anticipated amount and timing of cost savings relating to the restructuring plan, or its plans and objectives for future operations, growth initiatives, or strategies, 6 and the statements under the caption “ Full Year 2026 Guidance ” are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,” and variations of such words and similar expressions are intended to identify such forward-looking statements. All forward-looking statements are subject to risks and uncertainties, known and unknown, that may cause actual results to differ materially from those that the Company expected. Specific factors that could cause such a difference include, but are not limited to, those disclosed previously in the Company’s filings with the Securities and Exchange Commission (“SEC”). For more detail on the risk factors that may affect the Company’s results, see the section entitled “Risk Factors” in our most recent Annual Report on Form 10-K filed with the SEC, and in other documents filed with, or furnished to, the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Given these factors, as well as other variables that may affect the Company’s operating results, you are cautioned not to place undue reliance on these forward-looking statements, not to assume that past financial performance will be a reliable indicator of future performance, and not to use historical trends to anticipate results or trends in future periods. The forward-looking statements included in this press release and on the related earnings call relate only to events as of the date hereof. The Company does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions, or otherwise. Non-GAAP Financial Measures and Key Performance Indicators In assessing the performance of the Company’s business, non-GAAP financial measures are used that are derived from the Company’s consolidated financial information, but which are not presented in the Company’s consolidated financial statements prepared in accordance with GAAP. The Company considers these non-GAAP financial measures to be useful metrics for management and investors to facilitate operating performance comparisons from period to period by excluding potential differences caused by variations in capital structures, tax positions, depreciation, amortization, and certain other items that the Company believes are not representative of its core business. The Company uses the following non- GAAP measures for business planning purposes, in measuring performance relative to that of its competitors, to help investors to understand the nature of the Company’s growth, and to enable investors to evaluate the run-rate performance of the Company. Non-GAAP financial measures should be viewed as supplementing, and not as an alternative or substitute for, the consolidated financial statements prepared and presented in accordance with GAAP. The footnotes to the reconciliation tables below should be read in conjunction with the unaudited consolidated quarterly financial statements in the Company’s Quarterly Report on Form 10-Q filed with the SEC. Industry peers may provide similar supplemental information but may not define similarly-named metrics in the same way and may not make identical adjustments. Organic revenue growth rate: Organic revenue growth rate represents the percentage change in Net commissions and fees, as compared to the same period for the prior year, adjusted to eliminate revenue attributable to acquisitions for the first twelve months of ownership, revenue attributable to sold businesses for the subsequent twelve months after the sale, and other items such as contingent commissions and the impact of changes in foreign exchange rates. Adjusted compensation and benefits expense: Adjusted compensation and benefits expense is defined as Compensation and benefits expense adjusted to reflect items such as (i) equity-based compensation, (ii) acquisition and restructuring related compensation expenses, and (iii) other exceptional or non-recurring compensation expenses, as applicable. The most directly comparable GAAP financial metric is Compensation and benefits expense. Adjusted general and administrative expense: Adjusted general and administrative expense is defined as General and administrative expense adjusted to reflect items such as (i) acquisition and restructuring related general and administrative expenses, and (ii) other exceptional or non-recurring general and administrative expenses, as applicable. The most directly comparable GAAP financial metric is General and administrative expense. 7 Adjusted compensation and benefits expense ratio: Adjusted compensation and benefits expense ratio is defined as the Adjusted compensation and benefits expense as a percentage of Total revenue. The most directly comparable GAAP financial metric is Compensation and benefits expense ratio. Adjusted general and administrative expense ratio: Adjusted general and administrative expense ratio is defined as the Adjusted general and administrative expense as a percentage of Total revenue. The most directly comparable GAAP financial metric is General and administrative expense ratio. Adjusted EBITDAC: Adjusted EBITDAC is defined as Net income before Interest expense, net, Income tax expense, Depreciation, Amortization, and Change in contingent consideration, adjusted to reflect items such as (i) equity- based compensation, (ii) acquisition-related expenses, and (iii) other exceptional or non-recurring items, as applicable. Acquisition- related expense includes one-time diligence, transaction-related, and integration costs. Acquisition related long-term incentive compensation arises from long-term incentive plans associated with acquisitions. These plans require service requirements, and in some cases performance targets, to be met in order to be earned. Restructuring and related expense consists of compensation and benefits, contractors, professional services, and license fees related to the Empower Program, which was initiated at the beginning of 2026. Restructuring expense within general and administrative expense includes costs relating to professional services, technology and data initiatives, license fees, and third- party contractors, as well as non-cash expenses associated with the impairment of internally-developed software. Compensation and benefits restructuring costs include severance as well as employment costs for services rendered between the notification and termination dates and other termination payments. Amortization and expense is composed of charges related to discontinued prepaid incentive programs. For the three months ended September 30, 2026 , Other non-operating income consisted of $1.0 million of proceeds from the sales of a small non- subscription workers compensation book of business and a small MGU, $0.1 million of sublease income, and $0.1 million of forfeitures of vested equity awards offset by $0.5 million of TRA contractual interest and related charges. For the three months ended September 30, 2025, Other non- operating income consisted of $0.3 million of forfeitures of vested equity awards, $0.2 million of seller reimbursement of acquisition-related retention incentives, and $0.2 million of sublease income offset by $0.4 million of TRA contractual interest and related charges. For the nine months ended September 30, 2026 , Other non- operating income consisted of $1.1 million of proceeds from the sales of a small non- subscription workers compensation book of business and a small MGU, $0.7 million of forfeitures of vested equity awards, $0.4 million of sublease income, and $0.1 million of seller reimbursement of acquisition-related retention incentives offset by $0.8 million of TRA contractual interest and related charges. For the nine months ended September 30, 2025, Other non- operating income consisted of $0.6 million of seller reimbursement of acquisition-related retention incentives, $0.4 million of sublease income, and $0.3 million of forfeitures of vested equity awards offset by $0.8 million of TRA contractual interest and related charges. Equity-based compensation reflects non-cash equity-based expense. IPO related expenses consist of compensation-related expense primarily related to the expense for new awards issued at IPO as well as expense related to the revaluation of existing equity awards at IPO. Adjusted EBITDAC margin : Adjusted EBITDAC margin is defined as Adjusted EBITDAC as a percentage of Total revenue. The most directly comparable GAAP financial metric is Net income margin. Adjusted net income : Adjusted net income is defined as tax-effected earnings before amortization and certain items of income and expense, gains and losses, equity-based compensation, acquisition related long-term incentive compensation, acquisition-related expenses, costs associated with our IPO, and certain exceptional or non-recurring items. The Company is subject to United States federal income taxes, in addition to state, local, and foreign taxes, with respect to its allocable share of any net taxable income of Ryan Specialty, LLC (together with its parent New Ryan Specialty, LLC and their subsidiaries, the “LLC”). For comparability purposes, this calculation incorporates the impact of federal and state statutory tax rates on 100% of the Company’s adjusted pre- tax income as if the Company owned 100% of Ryan Specialty, LLC. The most directly comparable GAAP financial metric is Net income. Adjusted net income margin : Adjusted net income margin is defined as Adjusted net income as a percentage of Total revenue. The most directly comparable GAAP financial metric is Net income margin. Adjusted diluted earnings per share: Adjusted diluted earnings per share is defined as Adjusted net income divided by diluted shares outstanding after adjusting for the effect if 100% of the outstanding LLC Common Units (“LLC
Common Units”), together with the shares of Class B common stock, vested Class C Incentive Units, vested but unexercised options, and unvested equity awards were exchanged into shares of Class A common stock as if 100% of unvested equity awards were vested. The most directly comparable GAAP financial metric is Diluted earnings per share. Credit Adjusted EBITDAC: Credit Adjusted EBITDAC is defined as Adjusted EBITDAC as further adjusted without duplication for: acquired EBITDAC from the beginning of the applicable twelve month reference period through the acquisition close date, certain annualized run rate expected cost savings and initiatives, and certain other adjustments as permitted in calculating leverage ratios under our debt agreements. The Company presents Credit Adjusted EBITDAC as an additional measure of liquidity and leverage. The calculation of Credit Adjusted EBITDAC pursuant to our debt agreements permits certain estimates and assumptions that may differ from actual results. The summary unaudited consolidated financial data presented for the twelve months ended September 30, 2026 , was derived by adding the consolidated financial data of the Company for the twelve months ended December 31, 2025, to the consolidated financial data of the Company for the nine months ended September 30, 2026 , and subtracting the consolidated financial data of the Company for the nine months ended September 30, 2025 . The summary unaudited consolidated financial data for the twelve months ended September 30, 2026 , has been prepared for illustrative purposes only and is not necessarily representative of our results of operations for any future period or our financial condition at any future date. The reconciliation of the above non-GAAP measures to each of their most directly comparable GAAP financial measure is set forth in the reconciliation table accompanying this release. With respect to the Organic revenue growth rate and Adjusted EBITDAC margin outlook presented in the “ Full Year 2026 Guidance ” section of this press release, the Company is unable to provide a comparable outlook for, or a reconciliation to, Total revenue growth rate or Net income margin because it cannot provide a meaningful or accurate calculation or estimation of certain reconciling items without unreasonable effort. Its inability to do so is due to the inherent difficulty in forecasting the timing of items that have not yet occurred and quantifying certain amounts that are necessary for such reconciliation, including variations in effective tax rate, expenses to be incurred for acquisition activities, and other one-time or exceptional items. Contacts:
Investor RelationsNicholas MezickVP, Media RelationsAlice Phillips Investor RelationsRyan ToppingSVP, Chief Marketing & [email protected]: Communications OfficerRyan (312) 784-6152 SpecialtyAlice.Topping@ryanspecialty.… (312) 635-5976
Three Months Nine Months EndedSeptember EndedSeptember 30, 30, (in thousands, except percentages 2026 2025 2026 2025 and per share data) Non-GAAP financial measures* Organic revenue growth 4.0 % 15.0 % 7.3 % 11.4 % rate Adjusted compensation $443,373 $417,217 $1,400,151 $1,268,059 and benefits expense Adjusted compensation 56.1 % 55.3 % 56.0 % 55.1 % and benefits expense ratio Adjusted general and $102,144 $101,827 $298,306 $287,414 administrative expense Adjusted general and 12.9 % 13.5 % 11.9 % 12.5 % administrative expense ratio Adjusted $244,446 $235,533 $803,383 $744,440 EBITDAC Adjusted 30.9 % 31.2 % 32.1 % 32.4 % EBITDAC margin Adjusted net $137,121 $131,704 $466,581 $424,225 income Adjusted net 17.4 % 17.5 % 18.6 % 18.4 % income margin Adjusted diluted $0.51 $0.47 $1.75 $1.52 earnings per share
(in thousands, except share and per September 30,2026 December 31,2025 share data) ASSETS CURRENT ASSETS Cash and cash equivalents $168,811 $158,322 Commissions and fees receivable – net 576,111 488,951 Fiduciary cash and receivables 4,935,368 4,298,920 Prepaid incentives – net 28,660 13,550 Other current assets 76,615 100,437 Total current assets $5,785,565 $5,060,180 NON-CURRENT ASSETS Goodwill 3,216,252 3,225,021 Customer relationships 1,314,994 1,496,885 Other intangible assets 137,001 119,621 Prepaid incentives – net 26,827 27,849 Equity method investments 109,852 109,982 Property and equipment – net 64,665 69,461 Lease right-of-use assets 126,985 130,480 Deferred tax assets 252,220 310,138 Other non-current assets 9,972 14,554 Total non-current assets $5,258,768 $5,503,991 TOTAL ASSETS $11,044,333 $10,564,171 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued $308,128 $284,403 liabilities Accrued compensation 408,583 519,251 Operating lease liabilities 28,923 25,987 Tax Receivable Agreement liabilities 30,697 — Short-term debt and current portion of long-term 42,433 60,187 debt Fiduciary liabilities 4,935,368 4,298,920 Total current liabilities $5,754,132 $5,188,748 NON-CURRENT LIABILITIES Accrued compensation 90,878 70,096 Operating lease liabilities 150,020 153,089 Long-term debt 3,634,056 3,291,462 Tax Receivable Agreement liabilities 454,391 458,997 Deferred tax liabilities 43,547 49,834 Other non-current liabilities 15,561 97,894 Total non-current liabilities $4,388,453 $4,121,372 TOTAL LIABILITIES $10,142,585 $9,310,120 STOCKHOLDERS’ EQUITY Class A common stock ($0.001 par value; 1,000,000,000 shares authorized, 120,364,827and 129,603,426 shares issued and 120 130 outstanding at September 30, 2026 and December31, 2025, respectively) Class B common stock ($0.001 par value; 982,799,265 shares authorized and132,446,301 shares issued and outstanding at September 30, 132 135 2026; 1,000,000,000 sharesauthorized and 134,508,885 shares issued and outstanding at December 31, 2025) Preferred stock ($0.001 par value; 500,000,000 shares authorized, 0 shares issued — — andoutstanding at September 30, 2026, and December 31, 2025) Additional paid-in capital 271,892 513,610 Retained earnings 166,508 120,353 Accumulated other comprehensive 8,063 13,845 income Total stockholders’ equity attributable to Ryan $446,715 $648,073 Specialty Holdings, Inc. Non-controlling interests 455,033 605,978 Total stockholders’ equity $901,748 $1,254,051 TOTAL LIABILITIES AND STOCKHOLDERS’ $11,044,333 $10,564,171 EQUITY
Nine Months EndedSeptember 30, (in thousands) 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES Net income $237,026 $182,919 Adjustments to reconcile net income to cash flows provided by operating activities: Income from equity method -24,410 -15,050 investments Amortization 194,005 204,841 Depreciation 12,525 9,134 Prepaid and deferred compensation 30,096 33,613 expense Non-cash equity-based 51,968 50,988 compensation Amortization of deferred debt issuance 7,303 7,157 costs Amortization of interest rate cap — 5,216 premium Deferred income tax expense 26,782 11,472 Deferred income tax expense from common — 47,978 control reorganization Loss on Tax Receivable 834 783 Agreement Impairment of internally-developed 11,704 — software Changes in operating assets and liabilities, net of acquisitions:
Commissions and fees -89,099 -6,392 receivable – net Accrued interest liability -21,183 -12,489 Other current and non-current 18,464 19,520 assets Other current and non-current -149,082 -159,269 liabilities Total cash flows provided by operating $306,933 $380,421 activities CASH FLOWS FROM INVESTING ACTIVITIES Business combinations – net of cash acquired and cash held in a — -636,925 fiduciary capacity Capital expenditures -52,233 -50,678 Equity method investment in — -16,561 VSIC Proceeds from sale of equity method 23,349 — investment in VSIC Asset acquisitions -1,556 -3,014 Total cash flows used in investing $(30,440) $(707,178) activities CASH FLOWS FROM FINANCING ACTIVITIES Borrowings on Revolving Credit 1,359,030 1,114,872 Facility Repayments on Revolving Credit -1,008,719 -990,857 Facility Debt issuance costs paid — -2,889 Repayment of term debt -12,750 -12,750 Receipt of contingently returnable 3,140 1,927 consideration Payment of contingent -37,406 -29,252 consideration Tax distributions to non-controlling LLC -43,103 -45,695 Unitholders Receipt of taxes related to net share 18,831 35,174 settlement of equity awards Taxes paid related to net share -18,698 -36,051 settlement of equity awards Class A common stock dividends and -50,170 -46,825 Dividend Equivalents paid Distributions and Declared Distributions -24,233 -20,428 paid to non-controlling LLC Unitholders Repurchases of Class A common -450,253 — stock Payments related to Ryan Re preferred — -249 units Net change in fiduciary 183,520 38,341 liabilities Total cash flows provided by (used in) $(80,811) $5,318 financing activities Effect of changes in foreign exchange rates on cash, cash equivalents, and -5,872 14,507 cash and cashequivalents held in a fiduciary capacity NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS $189,810 $(306,932) HELD IN AFIDUCIARY CAPACITY CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A 1,584,470 1,680,805 FIDUCIARY CAPACITY—Beginning balance CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A $1,774,280 $1,373,873 FIDUCIARY CAPACITY—Ending balance Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciarycapacity Cash and cash equivalents $168,811 $153,485 Cash and cash equivalents held in a 1,605,469 1,220,388 fiduciary capacity Total cash, cash equivalents, and cash and cash equivalents held in a $1,774,280 $1,373,873 fiduciary capacity
Three Months Nine Months EndedSeptember EndedSeptember 30, 30, (in thousands, except 2026 2025 2026 2025 percentages) Current period Net commissions $775,081 $739,552 $2,460,712 $2,256,537 and fees revenue Less: Current period -29,107 -24,310 -95,629 -82,164 contingent commissions Less: Revenue attributable -55 -65 -147 -354 to sold businesses Net commissions and fees $745,919 $715,177 $2,364,936 $2,174,019 revenue excluding contingentcom… Prior period Net commissions $739,552 $588,129 $2,256,537 $1,806,264 and fees revenue Less: Prior year -24,310 -14,842 -82,164 -44,741 contingent commissions Less: Revenue attributable -1,161 -427 -2,343 -1,548 to sold businesses Prior period Net commissions and fees $714,081 $572,860 $2,172,030 $1,759,975 revenue excludingcont… commissions Change in Net commissions and fees $31,838 $142,317 $192,906 $414,044 revenue excludingcont… commissions Less: Mergers and acquisitions Net commissions -3,574 -55,650 -30,249 -212,249 and feesrevenue excluding contingent commissions Impact of change in foreign 219 -923 -3,878 -1,324 exchange rates Organic revenue growth $28,483 $85,744 $158,779 $200,471 (Non-GAAP) Net commissions and fees 4.8 % 25.7 % 9.0 % 24.9 % revenue growth rate (GAAP) Less: Impact of contingent -0.3 -0.9 -0.1 -1.4 commissions (1) Net commissions and fees revenue 4.5 % 24.8 % 8.9 % 23.5 % excluding contingentcom… growth rate (2) Less: Mergers and acquisitions Net commissions and -0.5 -9.7 -1.4 -12.0 feesrevenue excluding contingent commissions (3) Impact of change in foreign — -0.1 -0.2 -0.1 exchange rates (4) Organic Revenue Growth 4.0 % 15.0 % 7.3 % 11.4 % Rate (Non-GAAP)
(1) Calculated by subtracting Net commissions and fees revenue growth rate from net commissions and fees revenue excluding contingent commissions growth rate and revenue from sold businesses. (2) Calculated by dividing the change in Total net commissions and fees revenue excluding contingent commissions by prior year net commissions and fees excluding contingent commissions and revenue from sold businesses. (3) Calculated by taking the Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions, representing the first twelve months of net commissions and fees revenue generated from acquisitions, divided by prior period net commissions and fees revenue excluding contingent commissions and revenue from sold businesses. (4) Calculated by taking the change in foreign exchange rates divided by prior period net commissions and fees revenue excluding contingent commissions and revenue from sold businesses.
Reconciliation of Adjusted Compensation and Benefits Expense to Compensation and Benefits Expense
Three Months Nine Months EndedSeptember EndedSeptember 30, 30, (in thousands, except 2026 2025 2026 2025 percentages) Total revenue $789,963 $754,577 $2,501,839 $2,299,913 Compensation and benefits $484,208 $440,434 $1,511,001 $1,355,995 expense Acquisition-r… -625 -3,583 -5,885 -8,546 expense Acquisition related long-term -6,791 -7,463 -17,185 -25,115 incentive compensation Restructuring and related -19,528 — -33,627 — expense Amortization and expense related to -663 -981 -2,185 -3,287 discontinued prepaidincent… Equity-based compensation -13,105 -7,432 -45,825 -36,854 (1) IPO related -123 -3,758 -6,143 -14,134 expenses Adjusted compensation $443,373 $417,217 $1,400,151 $1,268,059 and benefits expense (2) Compensation and benefits 61.3% 58.4% 60.4% 59.0% expense ratio Adjusted compensation 56.1% 55.3% 56.0% 55.1% and benefits expense ratio
(1) For the three months ended September 30, 2026, $9.2 million of expense was reversed associated with certain performance-based awards. For the three months ended September 30, 2025, $5.8 million of expense was reversed associated with certain executive performance-based awards. See “ Note 9 , Equity-Based Compensation ” of the unaudited quarterly consolidated financial statements for additional discussion. (2) Adjustments made to Compensation and benefits expense are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.” Reconciliation of Adjusted General and Administrative Expense to General and Administrative Expense
Three Months Nine Months EndedSeptember EndedSeptember 30, 30, (in thousands, except 2026 2025 2026 2025 percentages) Total revenue $789,963 $754,577 $2,501,839 $2,299,913 General and administrative $106,977 $117,589 $334,381 $330,698 expense Acquisition-r… -509 -15,762 -6,553 -43,284 expense Restructuring and related -4,324 — -29,522 — expense Adjusted general and $102,144 $101,827 $298,306 $287,414 administrative expense (1) General and administrative 13.5% 15.6% 13.4% 14.4% expense ratio Adjusted general and 12.9% 13.5% 11.9% 12.5% administrative expense ratio
(1) Adjustments made to General and administrative expense are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.”
(1) For the three months ended September 30, 2026, and for the nine months ended September 30, 2025, Change in contingent consideration included a $12.9 million and $14.3 million, respectively, decrease in valuation of the US Assure contingent consideration as a result of increased loss ratios impacting projected profit commissions.
(1) Interest expense, net includes amortization of deferred debt issuance costs. (2) Adjustments made to Net income are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.” (3) The Company is subject to United States federal income taxes, in addition to state, local, and foreign taxes, with respect to our allocable share of any net taxable income of the LLC. For the three and nine months ended September 30, 2026 and 2025 , this calculation of adjusted income tax expense is based on a federal statutory rate of 21% and a combined state income tax rate net of federal benefits of 5.00% on 100% of our adjusted income before income taxes as if the Company owned 100% of the LLC.
Reconciliation of Adjusted Diluted Earnings per Share to Diluted Earnings per Share
Three Months Nine Months EndedSeptember EndedSeptember 30, 30, 2026 2025 2026 2025 Earnings per share of Class $0.29 $0.20 $0.74 $0.41 A common stock – diluted Less: Net income attributed to -0.15 -0.09 -0.01 -0.01 dilutive shares (1) Plus: Impact of all LLC Common Units 0.20 0.12 0.16 0.27 exchanged for ClassA shares (2) Plus: Adjustments to Adjusted net 0.18 0.25 0.86 0.88 income (3) Plus: Dilutive impact of -0.01 -0.01 — -0.03 unvested equity awards (4) Adjusted diluted $0.51 $0.47 $1.75 $1.52 earnings per share (Share count in ’000) Weighted-avera… shares of Class A 262,162 273,462 132,485 138,090 common stockoutstandi… – diluted Plus: Impact of all LLC Common Units — — 133,980 135,644 exchanged for ClassA shares (2) Plus: Dilutive impact of 4,172 5,526 -393 5,407 unvested equity awards (4) Adjusted diluted earnings per 266,334 278,988 266,072 279,141 share diluted share count
(1) Adjustment removes the impact of Net income attributed to dilutive awards to arrive at Net income attributable to Ryan Specialty Holdings, Inc. For the three months ended September 30, 2026 and 2025 , this removes $38.0 million and $23.4 million of Net income, respectively, on 262.2 million and 273.5 million Weighted-average shares of Class A common stock outstanding - diluted, respectively. For the nine months ended September 30, 2026 and 2025 , this removes $1.0 million and $1.2 million of Net income, respectively, on 132.5 million and 138.1 million Weighted- average shares of Class A common stock outstanding - diluted, respectively. See “ Note 10 , Earnings Per Share ” of the unaudited quarterly consolidated financial statements. (2) For comparability purposes, this calculation incorporates the Net income that would be distributable if all LLC Common Units (together with shares of Class B common stock) were exchanged for shares of Class A common stock. For the three months ended September 30, 2026 and 2025 , this includes $51.4 million and $31.5 million of Net income, respectively, on 262.2 million and 273.5 million Weighted-average shares of Class A common stock outstanding - diluted, respectively. For the nine months ended September 30, 2026 and 2025 , this includes $140.4 million and $127.5 million of Net income, respectively, on 266.5 million and 273.7 million Weighted-average shares of Class A common stock outstanding - diluted, respectively. For the three months ended September 30, 2026, 133.3 million weighted-average outstanding LLC Common Units were considered dilutive and included in the 262.2 million Weighted-average shares of Class A common stock outstanding - diluted. For the three months ended September 30, 2025, 135.5 million weighted-average outstanding LLC Common Units were considered dilutive and included in the 273.5 million Weighted-average shares of Class A common stock outstanding - diluted. See “ Note 10 , Earnings Per Share ” of the unaudited quarterly consolidated financial statements. (3) Adjustments to Adjusted net income are described in the footnotes of “ Reconciliation of Adjusted Net Income to Net Income ” on 262.2 million and 273.5 million Weighted- average shares of Class A common stock outstanding - diluted for the three months ended September 30, 2026 and 2025 , respectively, and 266.5 million and 273.7 million Weighted-average shares of Class A common stock outstanding - diluted for the nine months ended September 30, 2026 and 2025 , respectively. (4) For comparability purposes and to be consistent with the treatment of the adjustments to arrive at Adjusted net income, the dilutive effect of 100% of the outstanding LLC Common Units (together with shares of Class B common stock) at the end of each period, vested Class C Incentive Units, vested but unexercised options, and unvested equity awards is calculated using the treasury stock method as if the weighted-average unrecognized cost associated with the awards was $0 over the period, less any unvested equity awards determined to be dilutive within the Diluted EPS calculation disclosed in “ Note 10 , Earnings Per Share ” of the unaudited quarterly consolidated financial statements. For the three months ended September 30, 2026 and 2025 , 4.2 million and 5.5 million shares were added to the calculation, respectively. For the nine months ended September 30, 2026 and 2025 , (0.4) million and 5.4 million shares were added to the calculation, respectively.
(in thousands) Twelve Months EndedSeptember 30, 2026 ────────────────────────────────────────────────────────────────────────────── Total Revenue $3,253,052 Net Income $268,264 Interest expense, net 220,844 Income tax expense 50,366 Depreciation 16,480 Amortization 263,590 Change in contingent consideration 50,142 EBITDAC $869,686 Acquisition-related expense 32,710 Acquisition related long-term incentive 18,651 compensation Restructuring and related expense 63,149 Amortization and expense related to discontinued 3,230 prepaid incentives Other non-operating loss (income) -1,576 Equity-based compensation 58,635 IPO related expenses 11,796 Income from equity method investments -30,596 Adjusted EBITDAC (1) $1,025,685 Credit adjustments (2) 59,731 Credit Adjusted EBITDAC $1,085,416
(1) Adjustments made to Net income are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators”. (2) Adjustments made to Adjusted EBITDAC represent (without duplication) additional adjustments permitted under our debt agreements.
Full text with the tables
1 RYAN SPECIALTY REPORTS THIRD QUARTER 2026 RESULTS - Total Revenue grew 4.7%
year-over-year to $790.0 million - - Organic Revenue Growth Rate* of 4.0% year-
over-year - - Net Income of $88.0 million , or $0.29 per diluted share - -
Adjusted EBITDAC* grew 3.8% year-over-year to $244.4 million - - Adjusted Net
Income* increased 4.1% year-over-year to $137.1 million - - Adjusted Diluted
Earnings Per Share* grew 8.5% to $0.51 per diluted share - - Returned $173.7
million to shareholders, including $150.0 million of share repurchases and $23.7
million of dividends and distributions - October 29, 2026 | CHICAGO, IL — Ryan
Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”), a
leading international specialty insurance firm, today announced results for the
third quarter ended September 30, 2026 . Third Quarter 2026 Highlights • Revenue
grew 4.7% year-over-year to $790.0 million , compared to $754.6 million in the
prior-year period • Organic Revenue Growth Rate* was 4.0% for the quarter,
compared to 15.0% in the prior-year period • Net Income increased 40.6% year-
over-year to $88.0 million , compared to $62.6 million in the prior-year period.
Diluted Earnings Per Share was $0.29 • Adjusted EBITDAC* increased 3.8% to
$244.4 million , compared to $235.5 million in the prior-year period • Adjusted
EBITDAC Margin* of 30.9% , compared to 31.2% in the prior-year period • Adjusted
Net Income* increased 4.1% to $137.1 million , compared to $131.7 million in the
prior-year period • Adjusted Diluted Earnings Per Share* increased 8.5% to $0.51
, compared to $0.47 in the prior-year period • Returned $173.7 million to
shareholders through $150.0 million of Class A common stock repurchases,
representing 3.5 million shares, and $23.7 million in dividends and
distributions “We are proud of our third quarter performance, in light of an
increasingly challenging market and against our toughest year over year
comparison,” said Patrick G. Ryan, Founder and Executive Chairman of Ryan
Specialty. “We grew total revenue 4.7%, driven by organic growth of 4.0%. We
grew Adjusted EBITDAC by 3.8% and Adjusted Diluted EPS by 8.5%. We continued
investing back into our business, with our second largest hiring class in late
2025, and displayed disciplined expense management, leading to an Adjusted
EBITDAC margin that is down only 30 basis points year to date. We also returned
capital to shareholders of over $500 million through dividends, distributions,
and share repurchases. These results reflect the strength of our brokers and
underwriters, and of the durable, scalable platform we have strategically built.
We are confident our team will continue to perform throughout this cycle and
emerge even stronger.” “Our team delivered in the face of one of the most
challenging markets we have ever seen, retaining high levels of existing
business, winning significant new business, and building our pipelines,” added
Timothy W. Turner, Chief Executive Officer of Ryan Specialty. “We continue to
deliver for our clients through our differentiated talent, deep specialty
expertise, and independence. We are investing in talent, technology, AI, and
data that will widen our moat. We remain focused on controlling what we can
control. We are well-positioned to keep winning and to create long- term value
for our shareholders.”
2
Summary of Third Quarter 2026 Results
Three Nine
Mont… Months
Ende… Ended…
30, Chan… 30, Change
──────────────────────────────────────────────────────────────────────────────
(in
tho…
exc…
per… 2026 2025 $ % 2026 2025 $ %
per
sha…
dat…
GAAP
fin…
mea…
Tot… $789… $754… $35,… 4.7% $2,50… $2,2… $201,… 8.8%
rev…
Net
com… 775,… 739,… 35,5… 4.8 2,460… 2,25… 204,1… 9.0
and
fees
Com…
and 484,… 440,… 43,7… 9.9 1,511… 1,35… 155,0… 11.4
ben…
Gen…
and 106,… 117,… -10,… -9.0 334,3… 330,… 3,683 1.1
adm…
Tot…
ope… 649,… 643,… 5,349 0.8 2,086… 1,89… 188,2… 9.9
exp…
Ope… 140,… 110,… 30,0… 27.1 415,7… 402,… 13,662 3.4
inc…
Net 88,0… 62,6… 25,4… 40.6 237,0… 182,… 54,107 29.6
inc…
Net
inc…
att…
to 36,6… 31,0… 5,596 18.0 96,642 55,4… 41,223 74.4
Rya…
Hol…
Inc.
Com…
and 61.3 58.4 59.0
ben… % % 60.4 % %
rat…
(1)
Gen…
and 13.5 15.6 14.4
adm… % % 13.4 % %
rat…
(2)
Net
inc… 11.1 8.3 % 9.5 % 8.0 %
mar… %
(3)
Ear…
per $0.30 $0.24 $0.77 $0.44
sha…
(4)
Dil…
ear…
per $0.29 $0.20 $0.74 $0.41
sha…
(4)
Non…
fin…
mea…
Org…
rev… 4.0 % 15.0 7.3 % 11.4
gro… % %
rate
Adj…
com… $443… $417… $26,… 6.3 % $1,40… $1,2… $132,… 10.4
and… %
exp…
Adj…
com… 56.1 55.3 55.1
and… % % 56.0 % %
exp…
rat…
Adj…
gen… $102… $101… $317 0.3 % $298,… $287… $10,8… 3.8 %
and…
exp…
Adj…
gen… 12.9 13.5 12.5
and… % % 11.9 % %
exp…
rat…
Adj… $244… $235… $8,9… 3.8 % $803,… $744… $58,9… 7.9 %
EBI…
Adj… 30.9 31.2 32.4
EBI… % % 32.1 % %
mar…
Adj… 10.0
net $137… $131… $5,4… 4.1 % $466,… $424… $42,3… %
inc…
Adj…
net 17.4 17.5 18.6 % 18.4
inc… % % %
mar…
Adj…
dil… $0.51 $0.47 $0.04 8.5 % $1.75 $1.52 $0.23 15.1
ear… %
per…
* For a definition and a reconciliation of Organic revenue growth rate, Adjusted
compensation and benefits expense, Adjusted compensation and benefits expense
ratio, Adjusted general and administrative expense, Adjusted general and
administrative expense ratio, Adjusted EBITDAC, Adjusted EBITDAC margin,
Adjusted net income, Adjusted net income margin, and Adjusted diluted earnings
per share to the most directly comparable GAAP measure, see “ Non-GAAP Financial
Measures and Key Performance Indicators ” below. (1) Compensation and benefits
expense ratio is defined as Compensation and benefits divided by Total revenue.
(2) General and administrative expense ratio is defined as General and
administrative expense divided by Total revenue. (3) Net income margin is
defined as Net income divided by Total revenue. (4) See “ Note 10 , Earnings Per
Share ” of the unaudited quarterly consolidated financial statements.
3 Third Quarter 2026 Review* Total revenue for the third quarter of 2026 was
$790.0 million , an increase of 4.7% compared to $754.6 million in the prior-
year period. This increase was primarily due to continued organic revenue growth
of 4.0% , driven by new client wins, strong renewal retention, and expanded
relationships with existing clients, coupled with continued flow into the
specialty and E&S markets, and modest amounts of revenue from acquisitions
completed within the trailing twelve months ended September 30, 2026 . We
experienced growth across the majority of our casualty lines, offset by a
moderate decline in our property portfolio. Total operating expenses for the
third quarter of 2026 were $649.1 million , a 0.8% increase compared to $643.8
million in the prior-year period. This increase was primarily due to higher
Compensation and benefits expenses resulting from growth in revenue and an
increase in Restructuring and related expense due to the Empower Program,
partially offset by a decrease in Acquisition-related expenses. General and
administrative expense decreased compared to the prior-year period due to a
decrease in Acquisition-related expenses, partially offset by an increase in
Restructuring and related expense due to the Empower Program. Change in
contingent consideration also decreased compared to the prior-year period. Net
income for the third quarter of 2026 increased 40.6% to $88.0 million , compared
to $62.6 million in the prior- year period, primarily driven by solid revenue
growth and relatively flat Total operating expenses, partially offset by a
higher Income tax expense. Adjusted EBITDAC grew 3.8% to $244.4 million from
$235.5 million in the prior-year period. Adjusted EBITDAC margin for the quarter
was 30.9% , compared to 31.2% in the prior-year period. The increase in Adjusted
EBITDAC was driven primarily by solid revenue growth, partially offset by higher
Adjusted compensation and benefits expense. Adjusted net income for the third
quarter of 2026 increased 4.1% to $137.1 million , compared to $131.7 million in
the prior-year period. Adjusted net income margin was 17.4% , compared to 17.5%
in the prior-year period. Adjusted diluted earnings per share for the third
quarter of 2026 increased 8.5% to $0.51 , compared to $0.47 in the prior-year
period. * For the definition of each of the non-GAAP measures referred to above,
as well as a reconciliation of such non-GAAP measures to their most directly
comparable GAAP measures, see “Non-GAAP Financial Measures and Key Performance
Indicators ” below.
4
Third Quarter 2026 Net Commissions and Fees by Specialty and Revenue by Type
Growth in Net commissions and fees in all specialties was primarily driven by
solid organic growth.
Three
Months
Ended
September
30,
(in
thousan… 2026 % oftotal 2025 % oftotal Change
except
percent…
Wholesa… $394,283 50.9% $376,788 50.9% $17,495 4.6%
Brokera…
Binding 93,012 12.0 89,636 12.1 3,376 3.8
Authori…
Underwr… 287,786 37.1 273,128 37.0 14,658 5.4
Managem…
Total
Net $775,081 $739,552 $35,529 4.8%
commiss…
and fees
Nine
Months
Ended
September
30,
(in
thousan… 2026 % 2025 % Change
except oftotal oftotal
percent…
Wholesa… $1,270,8… 51.7% $1,214,7… 53.8% $56,140 4.6%
Brokera…
Binding 303,182 12.3 286,110 12.7 17,072 6.0
Authori…
Underwr… 886,649 36.0 755,686 33.5 130,963 17.3
Managem…
Total
Net $2,460,7… $2,256,5… $204,175 9.0%
commiss…
and fees
The following tables set forth our revenue by type of commissions and fees:
Three
Months
Ended
September
30,
(in
thousan… 2026 % oftotal 2025 % Change
except oftotal
percent…
Net
commiss…
and $725,761 93.6% $672,942 91.0% $52,819 7.8%
policy
fees
Supplem…
and 33,781 4.4 29,782 4.0 3,999 13.4
conting…
Loss
mitigat…
and 15,539 2.0 36,828 5.0 -21,289 -57.8
other
fees
Total
Net $775,081 $739,552 $35,529 4.8%
commiss…
and fees
Nine
Months
Ended
September
30,
(in
thousa… 2026 % 2025 % Change
except oftotal oftotal
percen…
Net
commis…
and $2,295,6… 93.3% $2,083,9… 92.4% $211,716 10.2%
policy
fees
Supple…
and 115,066 4.7 103,185 4.6 11,881 11.5
contin…
Loss
mitiga…
and 49,947 2.0 69,369 3.0 -19,422 -28.0
other
fees
Total
Net
commis… $2,460,7… $2,256,5… $204,175 9.0%
and
fees
5 Liquidity and Financial Condition As of September 30, 2026 , the Company had
Cash and cash equivalents of $168.8 million and outstanding debt principal of
$3.7 billion . Capital Return In the third quarter, the Company returned
approximately $173.7 million to shareholders through $150.0 million of Class A
common stock repurchases, representing 3.5 million shares, and $23.7 million in
dividends and distributions. As of September 30, 2026 , the Company had $150.0
million of remaining authorization under its share repurchase program.
Additionally, on October 29, 2026 , the Company’s board of directors declared a
quarterly dividend of $0.13 per share on the outstanding Class A common stock.
The quarterly dividend will be payable on November 24, 2026 , to stockholders of
record as of the close of business on November 10, 2026 . A portion of the
dividend, $0.06 per share, will be funded by free cash flow from Ryan Specialty,
LLC and will be paid to all holders of the Company’s Class A common stock and
the holders of the LLC Common Units (as defined below). Full Year 2026 Guidance*
The Company is maintaining its full year 2026 guidance for Organic Revenue
Growth Rate and updating its Adjusted EBITDAC Margin as follows: • We are
guiding to an Organic Revenue Growth Rate in the mid-single digits for 2026 • We
are guiding to an Adjusted EBITDAC Margin that is down modestly for 2026, as
compared to the prior year * For a definition of Organic revenue growth rate and
Adjusted EBITDAC margin, see “ Non-GAAP Financial Measures and Key Performance
Indicators ” below. Conference Call Information Ryan Specialty will hold a
conference call to discuss the financial results at 4:45pm Eastern Time on
October 29, 2026 . Interested parties may access the conference call through the
live webcast, which can be accessed at https:// ryan-specialty-q3-2026-earnings-
call.open-exchange.net/registration or by visiting the Company’s Investor
Relations website. Please join the live webcast at least 10 minutes prior to the
scheduled start time. A webcast replay of the call will be available on the
Company’s website at ryanspecialty.com in its Investors section for one year
following the call. About Ryan Specialty Founded in 2010, Ryan Specialty (NYSE:
RYAN) is a service provider of specialty products and solutions for insurance
brokers, agents, and carriers. Ryan Specialty provides distribution,
underwriting, product development, administration, and risk management services
by acting as a wholesale broker and a managing underwriter with delegated
authority from insurance carriers. Our mission is to provide industry-leading
innovative specialty insurance solutions for insurance brokers, agents, and
carriers. Learn more at ryanspecialty.com. Forward-Looking Statements All
statements in this release and in the corresponding earnings call that are not
historical are “forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995 and involve substantial risks and
uncertainties. For example, all statements the Company makes relating to its
estimated and projected costs, expenditures, cash flows, growth rates and
financial results, its plans, anticipated amount and timing of cost savings
relating to the restructuring plan, or its plans and objectives for future
operations, growth initiatives, or strategies, 6 and the statements under the
caption “ Full Year 2026 Guidance ” are forward-looking statements. Words such
as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,”
“may,” “will,” “should,” “can have,” “likely,” and variations of such words and
similar expressions are intended to identify such forward-looking statements.
All forward-looking statements are subject to risks and uncertainties, known and
unknown, that may cause actual results to differ materially from those that the
Company expected. Specific factors that could cause such a difference include,
but are not limited to, those disclosed previously in the Company’s filings with
the Securities and Exchange Commission (“SEC”). For more detail on the risk
factors that may affect the Company’s results, see the section entitled “Risk
Factors” in our most recent Annual Report on Form 10-K filed with the SEC, and
in other documents filed with, or furnished to, the SEC. Should one or more of
these risks or uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated or
anticipated by such forward-looking statements. Given these factors, as well as
other variables that may affect the Company’s operating results, you are
cautioned not to place undue reliance on these forward-looking statements, not
to assume that past financial performance will be a reliable indicator of future
performance, and not to use historical trends to anticipate results or trends in
future periods. The forward-looking statements included in this press release
and on the related earnings call relate only to events as of the date hereof.
The Company does not undertake, and expressly disclaims, any duty or obligation
to update publicly any forward-looking statement after the date of this release,
whether as a result of new information, future events, changes in assumptions,
or otherwise. Non-GAAP Financial Measures and Key Performance Indicators In
assessing the performance of the Company’s business, non-GAAP financial measures
are used that are derived from the Company’s consolidated financial information,
but which are not presented in the Company’s consolidated financial statements
prepared in accordance with GAAP. The Company considers these non-GAAP financial
measures to be useful metrics for management and investors to facilitate
operating performance comparisons from period to period by excluding potential
differences caused by variations in capital structures, tax positions,
depreciation, amortization, and certain other items that the Company believes
are not representative of its core business. The Company uses the following non-
GAAP measures for business planning purposes, in measuring performance relative
to that of its competitors, to help investors to understand the nature of the
Company’s growth, and to enable investors to evaluate the run-rate performance
of the Company. Non-GAAP financial measures should be viewed as supplementing,
and not as an alternative or substitute for, the consolidated financial
statements prepared and presented in accordance with GAAP. The footnotes to the
reconciliation tables below should be read in conjunction with the unaudited
consolidated quarterly financial statements in the Company’s Quarterly Report on
Form 10-Q filed with the SEC. Industry peers may provide similar supplemental
information but may not define similarly-named metrics in the same way and may
not make identical adjustments. Organic revenue growth rate: Organic revenue
growth rate represents the percentage change in Net commissions and fees, as
compared to the same period for the prior year, adjusted to eliminate revenue
attributable to acquisitions for the first twelve months of ownership, revenue
attributable to sold businesses for the subsequent twelve months after the sale,
and other items such as contingent commissions and the impact of changes in
foreign exchange rates. Adjusted compensation and benefits expense: Adjusted
compensation and benefits expense is defined as Compensation and benefits
expense adjusted to reflect items such as (i) equity-based compensation, (ii)
acquisition and restructuring related compensation expenses, and (iii) other
exceptional or non-recurring compensation expenses, as applicable. The most
directly comparable GAAP financial metric is Compensation and benefits expense.
Adjusted general and administrative expense: Adjusted general and administrative
expense is defined as General and administrative expense adjusted to reflect
items such as (i) acquisition and restructuring related general and
administrative expenses, and (ii) other exceptional or non-recurring general and
administrative expenses, as applicable. The most directly comparable GAAP
financial metric is General and administrative expense. 7 Adjusted compensation
and benefits expense ratio: Adjusted compensation and benefits expense ratio is
defined as the Adjusted compensation and benefits expense as a percentage of
Total revenue. The most directly comparable GAAP financial metric is
Compensation and benefits expense ratio. Adjusted general and administrative
expense ratio: Adjusted general and administrative expense ratio is defined as
the Adjusted general and administrative expense as a percentage of Total
revenue. The most directly comparable GAAP financial metric is General and
administrative expense ratio. Adjusted EBITDAC: Adjusted EBITDAC is defined as
Net income before Interest expense, net, Income tax expense, Depreciation,
Amortization, and Change in contingent consideration, adjusted to reflect items
such as (i) equity- based compensation, (ii) acquisition-related expenses, and
(iii) other exceptional or non-recurring items, as applicable. Acquisition-
related expense includes one-time diligence, transaction-related, and
integration costs. Acquisition related long-term incentive compensation arises
from long-term incentive plans associated with acquisitions. These plans require
service requirements, and in some cases performance targets, to be met in order
to be earned. Restructuring and related expense consists of compensation and
benefits, contractors, professional services, and license fees related to the
Empower Program, which was initiated at the beginning of 2026. Restructuring
expense within general and administrative expense includes costs relating to
professional services, technology and data initiatives, license fees, and third-
party contractors, as well as non-cash expenses associated with the impairment
of internally-developed software. Compensation and benefits restructuring costs
include severance as well as employment costs for services rendered between the
notification and termination dates and other termination payments. Amortization
and expense is composed of charges related to discontinued prepaid incentive
programs. For the three months ended September 30, 2026 , Other non-operating
income consisted of $1.0 million of proceeds from the sales of a small non-
subscription workers compensation book of business and a small MGU, $0.1 million
of sublease income, and $0.1 million of forfeitures of vested equity awards
offset by $0.5 million of TRA contractual interest and related charges. For the
three months ended September 30, 2025, Other non- operating income consisted of
$0.3 million of forfeitures of vested equity awards, $0.2 million of seller
reimbursement of acquisition-related retention incentives, and $0.2 million of
sublease income offset by $0.4 million of TRA contractual interest and related
charges. For the nine months ended September 30, 2026 , Other non- operating
income consisted of $1.1 million of proceeds from the sales of a small non-
subscription workers compensation book of business and a small MGU, $0.7 million
of forfeitures of vested equity awards, $0.4 million of sublease income, and
$0.1 million of seller reimbursement of acquisition-related retention incentives
offset by $0.8 million of TRA contractual interest and related charges. For the
nine months ended September 30, 2025, Other non- operating income consisted of
$0.6 million of seller reimbursement of acquisition-related retention
incentives, $0.4 million of sublease income, and $0.3 million of forfeitures of
vested equity awards offset by $0.8 million of TRA contractual interest and
related charges. Equity-based compensation reflects non-cash equity-based
expense. IPO related expenses consist of compensation-related expense primarily
related to the expense for new awards issued at IPO as well as expense related
to the revaluation of existing equity awards at IPO. Adjusted EBITDAC margin :
Adjusted EBITDAC margin is defined as Adjusted EBITDAC as a percentage of Total
revenue. The most directly comparable GAAP financial metric is Net income
margin. Adjusted net income : Adjusted net income is defined as tax-effected
earnings before amortization and certain items of income and expense, gains and
losses, equity-based compensation, acquisition related long-term incentive
compensation, acquisition-related expenses, costs associated with our IPO, and
certain exceptional or non-recurring items. The Company is subject to United
States federal income taxes, in addition to state, local, and foreign taxes,
with respect to its allocable share of any net taxable income of Ryan Specialty,
LLC (together with its parent New Ryan Specialty, LLC and their subsidiaries,
the “LLC”). For comparability purposes, this calculation incorporates the impact
of federal and state statutory tax rates on 100% of the Company’s adjusted pre-
tax income as if the Company owned 100% of Ryan Specialty, LLC. The most
directly comparable GAAP financial metric is Net income. Adjusted net income
margin : Adjusted net income margin is defined as Adjusted net income as a
percentage of Total revenue. The most directly comparable GAAP financial metric
is Net income margin. Adjusted diluted earnings per share: Adjusted diluted
earnings per share is defined as Adjusted net income divided by diluted shares
outstanding after adjusting for the effect if 100% of the outstanding LLC Common
Units (“LLC
8
Common Units”), together with the shares of Class B common stock, vested Class C
Incentive Units, vested but unexercised options, and unvested equity awards were
exchanged into shares of Class A common stock as if 100% of unvested equity
awards were vested. The most directly comparable GAAP financial metric is
Diluted earnings per share. Credit Adjusted EBITDAC: Credit Adjusted EBITDAC is
defined as Adjusted EBITDAC as further adjusted without duplication for:
acquired EBITDAC from the beginning of the applicable twelve month reference
period through the acquisition close date, certain annualized run rate expected
cost savings and initiatives, and certain other adjustments as permitted in
calculating leverage ratios under our debt agreements. The Company presents
Credit Adjusted EBITDAC as an additional measure of liquidity and leverage. The
calculation of Credit Adjusted EBITDAC pursuant to our debt agreements permits
certain estimates and assumptions that may differ from actual results. The
summary unaudited consolidated financial data presented for the twelve months
ended September 30, 2026 , was derived by adding the consolidated financial data
of the Company for the twelve months ended December 31, 2025, to the
consolidated financial data of the Company for the nine months ended September
30, 2026 , and subtracting the consolidated financial data of the Company for
the nine months ended September 30, 2025 . The summary unaudited consolidated
financial data for the twelve months ended September 30, 2026 , has been
prepared for illustrative purposes only and is not necessarily representative of
our results of operations for any future period or our financial condition at
any future date. The reconciliation of the above non-GAAP measures to each of
their most directly comparable GAAP financial measure is set forth in the
reconciliation table accompanying this release. With respect to the Organic
revenue growth rate and Adjusted EBITDAC margin outlook presented in the “ Full
Year 2026 Guidance ” section of this press release, the Company is unable to
provide a comparable outlook for, or a reconciliation to, Total revenue growth
rate or Net income margin because it cannot provide a meaningful or accurate
calculation or estimation of certain reconciling items without unreasonable
effort. Its inability to do so is due to the inherent difficulty in forecasting
the timing of items that have not yet occurred and quantifying certain amounts
that are necessary for such reconciliation, including variations in effective
tax rate, expenses to be incurred for acquisition activities, and other one-time
or exceptional items. Contacts:
Investor RelationsNicholas MezickVP, Media RelationsAlice Phillips
Investor RelationsRyan ToppingSVP, Chief Marketing &
[email protected]: Communications OfficerRyan
(312) 784-6152 SpecialtyAlice.Topping@ryanspecialty.…
(312) 635-5976
9
Consolidated Statements of Income (Unaudited)
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except
percentages 2026 2025 2026 2025
and
per share
data)
Revenue
Net
commissions $775,081 $739,552 $2,460,712 $2,256,537
and fees
Fiduciary
investment 14,882 15,025 41,127 43,376
income
Total revenue $789,963 $754,577 $2,501,839 $2,299,913
Expenses
Compensation 484,208 440,434 1,511,001 1,355,995
and benefits
General and 106,977 117,589 334,381 330,698
administrative
Amortization 64,278 70,188 194,005 204,841
Depreciation 4,330 3,607 12,525 9,134
Change in
contingent -10,658 11,968 34,187 -2,833
consideration
Total
operating $649,135 $643,786 $2,086,099 $1,897,835
expenses
Operating $140,828 $110,791 $415,740 $402,078
income
Interest 57,264 56,344 167,646 169,186
expense, net
Income from
equity method -11,840 -4,957 -24,410 -15,050
investments
Other
non-operating -784 -402 -1,520 -636
income
Income before $96,188 $59,806 $274,024 $248,578
income taxes
Income tax
expense 8,140 -2,797 36,998 65,659
(benefit)
Net income $88,048 $62,603 $237,026 $182,919
GAAP financial
measures
Total revenue $789,963 $754,577 $2,501,839 $2,299,913
Net
commissions 775,081 739,552 2,460,712 2,256,537
and fees
Compensation 484,208 440,434 1,511,001 1,355,995
and benefits
General and 106,977 117,589 334,381 330,698
administrative
Net income 88,048 62,603 237,026 182,919
Compensation
and benefits 61.3 % 58.4 % 60.4 % 59.0 %
expense ratio
(1)
General and
administrative 13.5 % 15.6 % 13.4 % 14.4 %
expense ratio
(2)
Net income 11.1 % 8.3 % 9.5 % 8.0 %
margin (3)
Earnings per $0.30 $0.24 $0.77 $0.44
share (4)
Diluted
earnings per $0.29 $0.20 $0.74 $0.41
share (4)
Non-GAAP Financial Measures (Unaudited)
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except
percentages 2026 2025 2026 2025
and
per share
data)
Non-GAAP
financial
measures*
Organic
revenue growth 4.0 % 15.0 % 7.3 % 11.4 %
rate
Adjusted
compensation $443,373 $417,217 $1,400,151 $1,268,059
and benefits
expense
Adjusted
compensation 56.1 % 55.3 % 56.0 % 55.1 %
and benefits
expense ratio
Adjusted
general and $102,144 $101,827 $298,306 $287,414
administrative
expense
Adjusted
general and 12.9 % 13.5 % 11.9 % 12.5 %
administrative
expense ratio
Adjusted $244,446 $235,533 $803,383 $744,440
EBITDAC
Adjusted 30.9 % 31.2 % 32.1 % 32.4 %
EBITDAC margin
Adjusted net $137,121 $131,704 $466,581 $424,225
income
Adjusted net 17.4 % 17.5 % 18.6 % 18.4 %
income margin
Adjusted
diluted $0.51 $0.47 $1.75 $1.52
earnings per
share
10
Consolidated Balance Sheets (Unaudited)
(in thousands, except share and per September 30,2026 December 31,2025
share data)
ASSETS
CURRENT ASSETS
Cash and cash equivalents $168,811 $158,322
Commissions and fees receivable – net 576,111 488,951
Fiduciary cash and receivables 4,935,368 4,298,920
Prepaid incentives – net 28,660 13,550
Other current assets 76,615 100,437
Total current assets $5,785,565 $5,060,180
NON-CURRENT ASSETS
Goodwill 3,216,252 3,225,021
Customer relationships 1,314,994 1,496,885
Other intangible assets 137,001 119,621
Prepaid incentives – net 26,827 27,849
Equity method investments 109,852 109,982
Property and equipment – net 64,665 69,461
Lease right-of-use assets 126,985 130,480
Deferred tax assets 252,220 310,138
Other non-current assets 9,972 14,554
Total non-current assets $5,258,768 $5,503,991
TOTAL ASSETS $11,044,333 $10,564,171
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accrued $308,128 $284,403
liabilities
Accrued compensation 408,583 519,251
Operating lease liabilities 28,923 25,987
Tax Receivable Agreement liabilities 30,697 —
Short-term debt and current portion
of long-term 42,433 60,187
debt
Fiduciary liabilities 4,935,368 4,298,920
Total current liabilities $5,754,132 $5,188,748
NON-CURRENT LIABILITIES
Accrued compensation 90,878 70,096
Operating lease liabilities 150,020 153,089
Long-term debt 3,634,056 3,291,462
Tax Receivable Agreement liabilities 454,391 458,997
Deferred tax liabilities 43,547 49,834
Other non-current liabilities 15,561 97,894
Total non-current liabilities $4,388,453 $4,121,372
TOTAL LIABILITIES $10,142,585 $9,310,120
STOCKHOLDERS’ EQUITY
Class A common stock ($0.001 par
value;
1,000,000,000 shares authorized,
120,364,827and
129,603,426 shares issued and 120 130
outstanding at
September 30, 2026 and December31,
2025,
respectively)
Class B common stock ($0.001 par
value;
982,799,265 shares authorized
and132,446,301
shares issued and outstanding at
September 30, 132 135
2026; 1,000,000,000 sharesauthorized
and
134,508,885 shares issued and
outstanding at
December 31, 2025)
Preferred stock ($0.001 par value;
500,000,000
shares authorized, 0 shares issued — —
andoutstanding
at September 30, 2026, and December
31, 2025)
Additional paid-in capital 271,892 513,610
Retained earnings 166,508 120,353
Accumulated other comprehensive 8,063 13,845
income
Total stockholders’ equity
attributable to Ryan $446,715 $648,073
Specialty Holdings, Inc.
Non-controlling interests 455,033 605,978
Total stockholders’ equity $901,748 $1,254,051
TOTAL LIABILITIES AND STOCKHOLDERS’ $11,044,333 $10,564,171
EQUITY
11
Consolidated Statements of Cash Flows (Unaudited)
Nine Months EndedSeptember 30,
(in thousands) 2026 2025
CASH FLOWS FROM OPERATING
ACTIVITIES
Net income $237,026 $182,919
Adjustments to reconcile net
income to
cash flows provided by
operating
activities:
Income from equity method -24,410 -15,050
investments
Amortization 194,005 204,841
Depreciation 12,525 9,134
Prepaid and deferred
compensation 30,096 33,613
expense
Non-cash equity-based 51,968 50,988
compensation
Amortization of deferred debt
issuance 7,303 7,157
costs
Amortization of interest rate
cap — 5,216
premium
Deferred income tax expense 26,782 11,472
Deferred income tax expense
from common — 47,978
control reorganization
Loss on Tax Receivable 834 783
Agreement
Impairment of
internally-developed 11,704 —
software
Changes in operating assets
and
liabilities, net of
acquisitions:
Commissions and fees -89,099 -6,392
receivable – net
Accrued interest liability -21,183 -12,489
Other current and non-current 18,464 19,520
assets
Other current and non-current -149,082 -159,269
liabilities
Total cash flows provided by
operating $306,933 $380,421
activities
CASH FLOWS FROM INVESTING
ACTIVITIES
Business combinations – net of
cash
acquired and cash held in a — -636,925
fiduciary
capacity
Capital expenditures -52,233 -50,678
Equity method investment in — -16,561
VSIC
Proceeds from sale of equity
method 23,349 —
investment in VSIC
Asset acquisitions -1,556 -3,014
Total cash flows used in
investing $(30,440) $(707,178)
activities
CASH FLOWS FROM FINANCING
ACTIVITIES
Borrowings on Revolving Credit 1,359,030 1,114,872
Facility
Repayments on Revolving Credit -1,008,719 -990,857
Facility
Debt issuance costs paid — -2,889
Repayment of term debt -12,750 -12,750
Receipt of contingently
returnable 3,140 1,927
consideration
Payment of contingent -37,406 -29,252
consideration
Tax distributions to
non-controlling LLC -43,103 -45,695
Unitholders
Receipt of taxes related to
net share 18,831 35,174
settlement of equity awards
Taxes paid related to net
share -18,698 -36,051
settlement of equity awards
Class A common stock dividends
and -50,170 -46,825
Dividend Equivalents paid
Distributions and Declared
Distributions -24,233 -20,428
paid to non-controlling LLC
Unitholders
Repurchases of Class A common -450,253 —
stock
Payments related to Ryan Re
preferred — -249
units
Net change in fiduciary 183,520 38,341
liabilities
Total cash flows provided by
(used in) $(80,811) $5,318
financing activities
Effect of changes in foreign
exchange
rates on cash, cash
equivalents, and -5,872 14,507
cash and cashequivalents held
in a
fiduciary capacity
NET CHANGE IN CASH, CASH
EQUIVALENTS,
AND CASH AND CASH EQUIVALENTS $189,810 $(306,932)
HELD IN
AFIDUCIARY CAPACITY
CASH, CASH EQUIVALENTS, AND
CASH AND
CASH EQUIVALENTS HELD IN A 1,584,470 1,680,805
FIDUCIARY
CAPACITY—Beginning balance
CASH, CASH EQUIVALENTS, AND
CASH AND
CASH EQUIVALENTS HELD IN A $1,774,280 $1,373,873
FIDUCIARY
CAPACITY—Ending balance
Reconciliation of cash, cash
equivalents, and cash and cash
equivalents held in a
fiduciarycapacity
Cash and cash equivalents $168,811 $153,485
Cash and cash equivalents held
in a 1,605,469 1,220,388
fiduciary capacity
Total cash, cash equivalents,
and cash
and cash equivalents held in a $1,774,280 $1,373,873
fiduciary
capacity
12
Reconciliation of Organic Revenue Growth Rate
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except 2026 2025 2026 2025
percentages)
Current period
Net
commissions $775,081 $739,552 $2,460,712 $2,256,537
and fees
revenue
Less: Current
period -29,107 -24,310 -95,629 -82,164
contingent
commissions
Less: Revenue
attributable -55 -65 -147 -354
to sold
businesses
Net
commissions
and fees $745,919 $715,177 $2,364,936 $2,174,019
revenue
excluding
contingentcom…
Prior period
Net
commissions $739,552 $588,129 $2,256,537 $1,806,264
and fees
revenue
Less: Prior
year -24,310 -14,842 -82,164 -44,741
contingent
commissions
Less: Revenue
attributable -1,161 -427 -2,343 -1,548
to sold
businesses
Prior period
Net
commissions
and fees $714,081 $572,860 $2,172,030 $1,759,975
revenue
excludingcont…
commissions
Change in Net
commissions
and fees $31,838 $142,317 $192,906 $414,044
revenue
excludingcont…
commissions
Less: Mergers
and
acquisitions
Net
commissions -3,574 -55,650 -30,249 -212,249
and
feesrevenue
excluding
contingent
commissions
Impact of
change in
foreign 219 -923 -3,878 -1,324
exchange
rates
Organic
revenue growth $28,483 $85,744 $158,779 $200,471
(Non-GAAP)
Net
commissions
and fees 4.8 % 25.7 % 9.0 % 24.9 %
revenue growth
rate (GAAP)
Less: Impact
of contingent -0.3 -0.9 -0.1 -1.4
commissions
(1)
Net
commissions
and fees
revenue 4.5 % 24.8 % 8.9 % 23.5 %
excluding
contingentcom…
growth
rate (2)
Less: Mergers
and
acquisitions
Net
commissions
and -0.5 -9.7 -1.4 -12.0
feesrevenue
excluding
contingent
commissions
(3)
Impact of
change in
foreign — -0.1 -0.2 -0.1
exchange
rates (4)
Organic
Revenue Growth 4.0 % 15.0 % 7.3 % 11.4 %
Rate
(Non-GAAP)
(1) Calculated by subtracting Net commissions and fees revenue growth rate from
net commissions and fees revenue excluding contingent commissions growth rate
and revenue from sold businesses. (2) Calculated by dividing the change in Total
net commissions and fees revenue excluding contingent commissions by prior year
net commissions and fees excluding contingent commissions and revenue from sold
businesses. (3) Calculated by taking the Mergers and acquisitions Net
commissions and fees revenue excluding contingent commissions, representing the
first twelve months of net commissions and fees revenue generated from
acquisitions, divided by prior period net commissions and fees revenue excluding
contingent commissions and revenue from sold businesses. (4) Calculated by
taking the change in foreign exchange rates divided by prior period net
commissions and fees revenue excluding contingent commissions and revenue from
sold businesses.
13
Reconciliation of Adjusted Compensation and Benefits Expense to Compensation and
Benefits Expense
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except 2026 2025 2026 2025
percentages)
Total revenue $789,963 $754,577 $2,501,839 $2,299,913
Compensation
and benefits $484,208 $440,434 $1,511,001 $1,355,995
expense
Acquisition-r… -625 -3,583 -5,885 -8,546
expense
Acquisition
related
long-term -6,791 -7,463 -17,185 -25,115
incentive
compensation
Restructuring
and related -19,528 — -33,627 —
expense
Amortization
and expense
related to -663 -981 -2,185 -3,287
discontinued
prepaidincent…
Equity-based
compensation -13,105 -7,432 -45,825 -36,854
(1)
IPO related -123 -3,758 -6,143 -14,134
expenses
Adjusted
compensation $443,373 $417,217 $1,400,151 $1,268,059
and benefits
expense (2)
Compensation
and benefits 61.3% 58.4% 60.4% 59.0%
expense ratio
Adjusted
compensation 56.1% 55.3% 56.0% 55.1%
and benefits
expense ratio
(1) For the three months ended September 30, 2026, $9.2 million of expense was
reversed associated with certain performance-based awards. For the three months
ended September 30, 2025, $5.8 million of expense was reversed associated with
certain executive performance-based awards. See “ Note 9 , Equity-Based
Compensation ” of the unaudited quarterly consolidated financial statements for
additional discussion. (2) Adjustments made to Compensation and benefits expense
are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial
Measures and Key Performance Indicators.” Reconciliation of Adjusted General and
Administrative Expense to General and Administrative Expense
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except 2026 2025 2026 2025
percentages)
Total revenue $789,963 $754,577 $2,501,839 $2,299,913
General and
administrative $106,977 $117,589 $334,381 $330,698
expense
Acquisition-r… -509 -15,762 -6,553 -43,284
expense
Restructuring
and related -4,324 — -29,522 —
expense
Adjusted
general and $102,144 $101,827 $298,306 $287,414
administrative
expense (1)
General and
administrative 13.5% 15.6% 13.4% 14.4%
expense ratio
Adjusted
general and 12.9% 13.5% 11.9% 12.5%
administrative
expense ratio
(1) Adjustments made to General and administrative expense are described in the
definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key
Performance Indicators.”
14
Reconciliation of Adjusted EBITDAC to Net Income
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except 2026 2025 2026 2025
percentages)
Total revenue $789,963 $754,577 $2,501,839 $2,299,913
Net income $88,048 $62,603 $237,026 $182,919
Interest 57,264 56,344 167,646 169,186
expense, net
Income tax
expense 8,140 -2,797 36,998 65,659
(benefit)
Depreciation 4,330 3,607 12,525 9,134
Amortization 64,278 70,188 194,005 204,841
Change in
contingent -10,658 11,968 34,187 -2,833
consideration
(1)
EBITDAC $211,402 $201,913 $682,387 $628,906
Acquisition-r… 1,134 19,345 12,439 51,830
expense
Acquisition
related
long-term 6,791 7,463 17,185 25,115
incentive
compensation
Restructuring
and related 23,852 — 63,149 —
expense
Amortization
and expense
related to 663 981 2,185 3,287
discontinuedp…
incentives
Other
non-operating -784 -402 -1,520 -636
income
Equity-based 13,105 7,432 45,825 36,854
compensation
IPO related 123 3,758 6,143 14,134
expenses
Income from
equity method -11,840 -4,957 -24,410 -15,050
investments
Adjusted $244,446 $235,533 $803,383 $744,440
EBITDAC
Net income 11.1% 8.3% 9.5% 8.0%
margin
Adjusted 30.9% 31.2% 32.1% 32.4%
EBITDAC margin
(1) For the three months ended September 30, 2026, and for the nine months ended
September 30, 2025, Change in contingent consideration included a $12.9 million
and $14.3 million, respectively, decrease in valuation of the US Assure
contingent consideration as a result of increased loss ratios impacting
projected profit commissions.
15
Reconciliation of Adjusted Net Income to Net Income
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
(in thousands,
except 2026 2025 2026 2025
percentages)
Total revenue $789,963 $754,577 $2,501,839 $2,299,913
Net income $88,048 $62,603 $237,026 $182,919
Income tax
expense 8,140 -2,797 36,998 65,659
(benefit)
Amortization 64,278 70,188 194,005 204,841
Amortization
of deferred 2,447 2,397 7,303 7,157
debt issuance
costs (1)
Change in
contingent -10,658 11,968 34,187 -2,833
consideration
Acquisition-r… 1,134 19,345 12,439 51,830
expense
Acquisition
related
long-term 6,791 7,463 17,185 25,115
incentive
compensation
Restructuring
and related 23,852 — 63,149 —
expense
Amortization
and expense
related to 663 981 2,185 3,287
discontinuedp…
incentives
Other
non-operating -784 -402 -1,520 -636
income
Equity-based 13,105 7,432 45,825 36,854
compensation
IPO related 123 3,758 6,143 14,134
expenses
Income from
equity method -11,840 -4,957 -24,410 -15,050
investments
Adjusted
income before $185,299 $177,979 $630,515 $573,277
income taxes
(2)
Adjusted
income tax -48,178 -46,275 -163,934 -149,052
expense (3)
Adjusted net $137,121 $131,704 $466,581 $424,225
income
Net income 11.1% 8.3% 9.5% 8.0%
margin
Adjusted net 17.4% 17.5% 18.6% 18.4%
income margin
(1) Interest expense, net includes amortization of deferred debt issuance costs.
(2) Adjustments made to Net income are described in the definition of Adjusted
EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.” (3) The
Company is subject to United States federal income taxes, in addition to state,
local, and foreign taxes, with respect to our allocable share of any net taxable
income of the LLC. For the three and nine months ended September 30, 2026 and
2025 , this calculation of adjusted income tax expense is based on a federal
statutory rate of 21% and a combined state income tax rate net of federal
benefits of 5.00% on 100% of our adjusted income before income taxes as if the
Company owned 100% of the LLC.
16
Reconciliation of Adjusted Diluted Earnings per Share to Diluted Earnings per
Share
Three Months Nine Months
EndedSeptember EndedSeptember
30, 30,
2026 2025 2026 2025
Earnings per
share of Class $0.29 $0.20 $0.74 $0.41
A common
stock – diluted
Less: Net
income
attributed to -0.15 -0.09 -0.01 -0.01
dilutive
shares (1)
Plus: Impact of
all LLC Common
Units 0.20 0.12 0.16 0.27
exchanged for
ClassA shares
(2)
Plus:
Adjustments to
Adjusted net 0.18 0.25 0.86 0.88
income
(3)
Plus: Dilutive
impact of -0.01 -0.01 — -0.03
unvested equity
awards (4)
Adjusted
diluted $0.51 $0.47 $1.75 $1.52
earnings per
share
(Share count in
’000)
Weighted-avera…
shares of Class
A 262,162 273,462 132,485 138,090
common
stockoutstandi…
– diluted
Plus: Impact of
all LLC Common
Units — — 133,980 135,644
exchanged for
ClassA shares
(2)
Plus: Dilutive
impact of 4,172 5,526 -393 5,407
unvested equity
awards (4)
Adjusted
diluted
earnings per 266,334 278,988 266,072 279,141
share
diluted share
count
(1) Adjustment removes the impact of Net income attributed to dilutive awards to
arrive at Net income attributable to Ryan Specialty Holdings, Inc. For the three
months ended September 30, 2026 and 2025 , this removes $38.0 million and $23.4
million of Net income, respectively, on 262.2 million and 273.5 million
Weighted-average shares of Class A common stock outstanding - diluted,
respectively. For the nine months ended September 30, 2026 and 2025 , this
removes $1.0 million and $1.2 million of Net income, respectively, on 132.5
million and 138.1 million Weighted- average shares of Class A common stock
outstanding - diluted, respectively. See “ Note 10 , Earnings Per Share ” of the
unaudited quarterly consolidated financial statements. (2) For comparability
purposes, this calculation incorporates the Net income that would be
distributable if all LLC Common Units (together with shares of Class B common
stock) were exchanged for shares of Class A common stock. For the three months
ended September 30, 2026 and 2025 , this includes $51.4 million and $31.5
million of Net income, respectively, on 262.2 million and 273.5 million
Weighted-average shares of Class A common stock outstanding - diluted,
respectively. For the nine months ended September 30, 2026 and 2025 , this
includes $140.4 million and $127.5 million of Net income, respectively, on 266.5
million and 273.7 million Weighted-average shares of Class A common stock
outstanding - diluted, respectively. For the three months ended September 30,
2026, 133.3 million weighted-average outstanding LLC Common Units were
considered dilutive and included in the 262.2 million Weighted-average shares of
Class A common stock outstanding - diluted. For the three months ended September
30, 2025, 135.5 million weighted-average outstanding LLC Common Units were
considered dilutive and included in the 273.5 million Weighted-average shares of
Class A common stock outstanding - diluted. See “ Note 10 , Earnings Per Share ”
of the unaudited quarterly consolidated financial statements. (3) Adjustments to
Adjusted net income are described in the footnotes of “ Reconciliation of
Adjusted Net Income to Net Income ” on 262.2 million and 273.5 million Weighted-
average shares of Class A common stock outstanding - diluted for the three
months ended September 30, 2026 and 2025 , respectively, and 266.5 million and
273.7 million Weighted-average shares of Class A common stock outstanding -
diluted for the nine months ended September 30, 2026 and 2025 , respectively.
(4) For comparability purposes and to be consistent with the treatment of the
adjustments to arrive at Adjusted net income, the dilutive effect of 100% of the
outstanding LLC Common Units (together with shares of Class B common stock) at
the end of each period, vested Class C Incentive Units, vested but unexercised
options, and unvested equity awards is calculated using the treasury stock
method as if the weighted-average unrecognized cost associated with the awards
was $0 over the period, less any unvested equity awards determined to be
dilutive within the Diluted EPS calculation disclosed in “ Note 10 , Earnings
Per Share ” of the unaudited quarterly consolidated financial statements. For
the three months ended September 30, 2026 and 2025 , 4.2 million and 5.5 million
shares were added to the calculation, respectively. For the nine months ended
September 30, 2026 and 2025 , (0.4) million and 5.4 million shares were added to
the calculation, respectively.
17
Reconciliation of Credit Adjusted EBITDAC to Net Income
(in thousands) Twelve Months EndedSeptember 30, 2026
──────────────────────────────────────────────────────────────────────────────
Total Revenue $3,253,052
Net Income $268,264
Interest expense, net 220,844
Income tax expense 50,366
Depreciation 16,480
Amortization 263,590
Change in contingent consideration 50,142
EBITDAC $869,686
Acquisition-related expense 32,710
Acquisition related long-term
incentive 18,651
compensation
Restructuring and related expense 63,149
Amortization and expense related to
discontinued 3,230
prepaid incentives
Other non-operating loss (income) -1,576
Equity-based compensation 58,635
IPO related expenses 11,796
Income from equity method investments -30,596
Adjusted EBITDAC (1) $1,025,685
Credit adjustments (2) 59,731
Credit Adjusted EBITDAC $1,085,416
(1) Adjustments made to Net income are described in the definition of Adjusted
EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators”. (2)
Adjustments made to Adjusted EBITDAC represent (without duplication) additional
adjustments permitted under our debt agreements.